New Delhi, Dec. 10 -- The growth of the Indian pharmaceuticals market (IPM) continues to remain muted in November, staying in single-digit territory for the past 32 months, Nomura said in its latest report.

The report highlighted that the India pharmaceuticals market (IPM) grew 9.1 per cent year-over-year (y-o-y) (in terms of sales) in November 2025, reflecting a modest slowdown from the previous month, but still indicating some recovery in the recent past.

It stated "The India pharmaceuticals market (IPM) grew 9.1 per cent y-y (in terms of sales) in Nov-2025....... IPM growth has remained in single-digits for the past 32 months".

According to the report, the IPM recorded price growth of 5.5 per cent, while new products contributed 2.9...